President & CEO - The Methodist Hospital Research Institute - Texas, USA
Mauro Ferrari, Ph.D., is President and CEO of Houston Methodist Research Institute (USA), where he directs more than 2,300 employees and credentialed clinicians engaged in basic science and over 1,000 clinical research protocols in cancer, cardiovascular diseases, neurology, and many others domains of medicine. He also serves as Executive Vice President of the Houston Methodist Hospital System, recently recognized by U.S. News & World Report as one of the top twenty hospitals in the USA. Concurrently, Mauro Ferrari serves as Senior Associate Dean and Professor of Medicine at Weill Cornell Medical School in Manhattan, New York. His laboratory develops new drugs for cancer. He is recognized as the pioneer of nanomedicine and transport oncophysics. He has published over 500 scientific articles and 7 books, and is the inventor of over 50 patents issued in the USA and worldwide. He has won numerous scientific awards and recognitions. Mauro Ferrari is a Foreign Member of the Italian National Academy of Sciences (Accademia dei Quaranta) and a Corresponding Member of the Pontifical Academy for Life, by appointment of Pope Francis. His prior employment records include tenured faculty positions in Engineering at the University of California, Berkeley, and in Engineering and Medicine at The Ohio State University and at the University of Texas Medical School in Houston, before accepting his current positions with Houston Methodist Hospital. Born in Italy, Mauro Ferrari holds a degree in Mathematics from the University of Padua, a Master and Ph.D. in Mechanical Engineering from the University of California, Berkeley, and attended medical school at The Ohio State University. He received his executive leadership education at the Harvard Business School, and the CEO Academy of the Wharton School of Business of the University of Pennsylvania.